National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Chronic Lymphocytic Leukemia Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 05/22/2009



Purpose of This PDQ Summary






General Information About Chronic Lymphocytic Leukemia






Stage Information for Chronic Lymphocytic Leukemia






Treatment Option Overview






Stage 0 Chronic Lymphocytic Leukemia






Stage I, II, III, and IV Chronic Lymphocytic Leukemia






Refractory Chronic Lymphocytic Leukemia






Get More Information From NCI







Changes to This Summary (05/22/2009)






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Changes to This Summary (05/22/2009)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information About Chronic Lymphocytic Leukemia

Updated statistics with estimated new cases and deaths for 2009 (cited American Cancer Society).

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov